Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomised Marker-based Trial to Assess the Clinical Utility and Safety of Biomarker-guided Immunosuppression Withdrawal in Liver Transplantation

NCT02498977 is registered in ClinicalTrials.gov with King's College London as lead sponsor.

NCT NCT02498977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02498977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomised Marker-based Trial to Assess the Clinical Utility and Safety of Biomarker-guided Immunosuppression Withdrawal in Liver Transplantation
Lead sponsor
King's College London
Phase
Phase 4
Overall status
Terminated
Start date
October 31, 2015
Completion date
December 31, 2021
Enrollment
116 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

transplantation, liver